FDA.reportPublic FDA data

bendamustine HCl 25 MG/ML Injectable Solution

RxCUI
1726097
RxNorm name
bendamustine HCl 25 MG/ML Injectable Solution
Display name
bendamustine HCl 25 MG/ML Injectable Solution
Full name
bendamustine HCl 25 MG/ML Injectable Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BENDAMUSTINE HYDROCHLORIDEBENDAMUSTINE HYDROCHLORIDEAvyxa Pharma, LLCf359e7c6-d104-457d-a7fe-597c744403532026-05-14Warnings, Adverse reactionsExact identifier
rxcui: 1726097
Bendamustine HydrochlorideBENDAMUSTINE HYDROCHLORIDEApotex Corp085dd54c-4212-d879-afef-ee52732a48c02025-09-16Warnings, Adverse reactionsExact identifier
rxcui: 1726097
VIVIMUSTABENDAMUSTINE HYDROCHLORIDEAzurity Pharmaceuticals, Inc.4df6548f-c4ad-4eb2-a54f-19766a3d90ca2025-04-03Warnings, Adverse reactionsExact identifier
rxcui: 1726097
BENDAMUSTINE HYDROCHLORIDEBENDAMUSTINE HYDROCHLORIDEBaxter Healthcare Corporation766b73e2-49bb-47f9-bbb1-44cfa1a3197e2025-02-10Warnings, Adverse reactionsExact identifier
rxcui: 1726097
BELRAPZOBENDAMUSTINE HYDROCHLORIDEEagle Pharmaceuticals, Inc9759a4ae-82ca-40cf-9c02-e1cadb21cbdc2024-09-23Warnings, Adverse reactionsExact identifier
rxcui: 1726097
VIVIMUSTABENDAMUSTINE HYDROCHLORIDESlayback Pharma LLCcbcc6eb7-aa62-4599-af49-05203fedb4bb2024-02-27Warnings, Adverse reactionsExact identifier
rxcui: 1726097
BendekaBENDAMUSTINE HYDROCHLORIDETeva Pharmaceuticals USA, Inc.ace9a43b-f9bd-4896-abfe-0ef4fec67ddf2024-01-19Warnings, Adverse reactionsExact identifier
rxcui: 1726097

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 7 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
cbcc6eb7-aa62-4599-af49-05203fedb4bbbendamustine HCl 25 MG/ML Injectable Solution [PSN] · bendamustine hydrochloride 25 MG/ML Injectable Solution [SCD]222These highlights do not include all the information needed to use VIVIMUSTA safely and effectively. See full prescribing information for VIVIMUSTA. VIVIMUSTA® (bendamustine hydrochloride injection), for intravenous use. Initial U.S. Approval: 200820240227
ace9a43b-f9bd-4896-abfe-0ef4fec67ddfbendamustine HCl 25 MG/ML Injectable Solution [PSN] · bendamustine hydrochloride 25 MG/ML Injectable Solution [SCD]222These highlights do not include all the information needed to use BENDEKA safely and effectively. See full prescribing information for BENDEKA. BENDEKA ® (bendamustine hydrochloride injection), for intravenous use Initial U.S. Approval: 200820240119
766b73e2-49bb-47f9-bbb1-44cfa1a3197ebendamustine HCl 25 MG/ML Injectable Solution [PSN] · bendamustine hydrochloride 25 MG/ML Injectable Solution [SCD]211These highlights do not include all the information needed to use BENDAMUSTINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BENDAMUSTINE HYDROCHLORIDE INJECTION. BENDAMUSTINE HYDROCHLORIDE injection, for intravenous use. Initial U.S. Approval: 200820250210
9759a4ae-82ca-40cf-9c02-e1cadb21cbdcbendamustine HCl 25 MG/ML Injectable Solution [PSN] · bendamustine hydrochloride 25 MG/ML Injectable Solution [SCD]211These highlights do not include all the information needed to use BELRAPZO safely and effectively. See full prescribing information for BELRAPZO. BELRAPZO ® (bendamustine hydrochloride injection), for intravenous use. Initial U.S. Approval: 200820240923
085dd54c-4212-d879-afef-ee52732a48c0bendamustine HCl 25 MG/ML Injectable Solution [PSN] · bendamustine hydrochloride 25 MG/ML Injectable Solution [SCD]28These highlights do not include all the information needed to use BENDAMUSTINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BENDAMUSTINE HYDROCHLORIDE INJECTION. BENDAMUSTINE HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 200820250916
4df6548f-c4ad-4eb2-a54f-19766a3d90cabendamustine HCl 25 MG/ML Injectable Solution [PSN] · bendamustine hydrochloride 25 MG/ML Injectable Solution [SCD]22These highlights do not include all the information needed to use VIVIMUSTA safely and effectively. See full prescribing information for VIVIMUSTA. VIVIMUSTA® (bendamustine hydrochloride injection), for intravenous use. Initial U.S. Approval: 200820250403
f359e7c6-d104-457d-a7fe-597c74440353bendamustine HCl 25 MG/ML Injectable Solution [PSN] · bendamustine hydrochloride 25 MG/ML Injectable Solution [SCD]21These highlights do not include all the information needed to use BENDAMUSTINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BENDAMUSTINE HYDROCHLORIDE INJECTION. BENDAMUSTINE HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 200820260514